1/9
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Ezetimibe
LDL ↓: Yes; TG ↓: No/none listed; Combo with statin: Yes; Clinical trial evidence for CV event reduction: Yes (marked *)
Bile acid sequestrants
LDL ↓: Yes; TG ↓: May raise TG; Combo with statin: Yes; Clinical trial evidence for CV event reduction: Yes (marked *)
Fibrate
LDL ↓: (not listed as primary); TG ↓: Yes; Combo with statin: Yes (fenofibrate preferred); Clinical trial evidence for CV event reduction: Yes (marked *)
Niacin
LDL ↓: Yes; TG ↓: Yes; Combo with statin: Yes; Clinical trial evidence for CV event reduction: No asterisk on slide
Omega-3 Fatty Acids
LDL ↓: May raise LDL; TG ↓: Yes; Combo with statin: Yes; Clinical trial evidence for CV event reduction: Yes (marked *)
PCSK9 Inhibitors
LDL ↓: Yes; TG ↓: (not listed as primary); Combo with statin: Yes; Clinical trial evidence for CV event reduction: Yes (marked *)
Bempedoic Acid
LDL ↓: Yes; TG ↓: (not listed); Combo with statin: Yes; Clinical trial evidence for CV event reduction: Yes (marked *)
Inclisiran
LDL ↓: Yes; TG ↓: (not listed); Combo with statin: Yes; Clinical trial evidence for CV event reduction: No asterisk on slide
Mipomersen
LDL ↓: Yes; TG ↓: (not listed); Combo with statin: Yes; Clinical trial evidence for CV event reduction: No asterisk on slide
Lomitapide
LDL ↓: Yes; TG ↓: (not listed); Combo with statin: Yes; Clinical trial evidence for CV event reduction: No asterisk on slide